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Abstract
Adenoviruses are important human pathogens that have been developed as vectors for gene therapies and genetic
vaccines. Previous studies indicated that human infections with adenoviruses are self-limiting in immunocompetent hosts
with evidence of some persistence in adenoid tissue. We sought to better understand the natural history of adenovirus
infections in various non-human primates and discovered that healthy populations of great apes (chimpanzees, bonobos,
gorillas, and orangutans) and macaques shed substantial quantities of infectious adenoviruses in stool. Shedding in stools
from asymptomatic humans was found to be much less frequent, comparable to frequencies reported before. We purified
and fully sequenced 30 novel adenoviruses from apes and 3 novel adenoviruses from macaques. Analyses of the new ape
adenovirus sequences (as well as the 4 chimpanzee adenovirus sequences we have previously reported) together with 22
complete adenovirus genomes available from GenBank revealed that (a) the ape adenoviruses could clearly be classified
into species corresponding to human adenovirus species B, C, and E, (b) there was evidence for intraspecies recombination
between adenoviruses, and (c) the high degree of phylogenetic relatedness of adenoviruses across their various primate
hosts provided evidence for cross species transmission events to have occurred in the natural history of B and E viruses. The
high degree of asymptomatic shedding of live adenovirus in non-human primates and evidence for zoonotic transmissions
warrants caution for primate handling and housing. Furthermore, the presence of persistent and/or latent adenovirus
infections in the gut should be considered in the design and interpretation of human and non-human primate studies with
adenovirus vectors.
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Introduction
Adenoviruses were first discovered in the 1950s as outgrowths
from human adenoid and tonsil explants. They naturally infect
many different vertebrates including humans. Isolates were
originally found to differ in their ability to agglutinate rat and
rhesus erythrocytes and these properties were used to classify
adenoviruses into four subgroups [1]. Subsequently, other
prominent attributes of adenoviruses, e.g., the ability to induce
tumors in rodents, the molecular masses of capsid proteins as
determined by electrophoresis [2] and GC content of the genome
[3] were used to augment the four initial subgroups to the six
(subgroups A to F, currently referred to as species HAdV-A
through HAdV-F) that are commonly accepted today. As
complete sequences of the human adenoviruses have become
available and phylogenic analyses of the component proteins have
become possible, the original classifications have been confirmed
to be reasonably valid although some reservation has been
expressed regarding the justification of assigning a separate
subgroup (E) to its only defined human adenovirus member,
HAdV-4 [4].
Infections with HAdV-C are a common cause of pediatric
upper respiratory tract infections worldwide; later in life HAdV-B
has been found to the cause of epidemics in adults. Both HAdV-B
and HAdV-E have been found to the etiologic agents for infections
in the setting of military boot camps [5]. Surveys for the
prevalence of neutralizing antibodies have been conducted in
order to determine the probable success of recombinant
adenoviral vaccines [6], where the prevalence of antibodies to
HAdV-C has found to be high in Europe, USA and Africa [7]. In
contrast, the prevalence of antibodies to HAdV-B has been found
PLoS Pathogens | www.plospathogens.org 1 July 2009 | Volume 5 | Issue 7 | e1000503to be comparatively lower in a European cohort [8]. HAdV-F is
frequently implicated as a cause of infectious diarrheas worldwide
[9–14], but other adenovirus serotypes were also frequently co-
isolated under these conditions.
The molecular biology of primate adenoviruses has been
defined in substantial detail [15]. Less is known about the natural
history of naturally occurring adenovirus infections. Recombinant
forms of human adenoviruses have been aggressively pursued as
vectors for human gene therapy and genetic vaccines [16].
Natural history studies of large cohorts of families in Seattle [17]
and Long Island [18] showed that clinical sequelae of adenovirus
infections and recovery of virus in immune competent humans are
self–limited, although prolonged shedding was observed in stool
from a subset of individuals. An early clue to the biology of
adenovirus infections in great apes was provided by Hillis in 1963
in a study which attempted to isolate the cause of transmissible
hepatitis in chimpanzees [19]. He recovered from stool of 25/87
chimpanzees an uncharacterized cytopathic virus that grew in vitro
but was not related to hepatitis. He concluded that ‘‘there are a
number of enterically excreted viruses in the chimpanzee, some or
all of which may be part of the animal’s ‘normal flora’ ’’.
Results
To better understand the natural history of adenovirus
infections in primates, we investigated virus persistence and
latency in species of the Hominidae and the Cercopithecidae
family. Samples were acquired from several great ape species:
chimpanzee (Pan troglodytes), bonobo (Pan paniscus), orangutan
(Pongo pygmaeus) and gorilla (Gorilla gorilla) as well as normal
humans. Two old world monkey species, rhesus and cynomolgus
macaques (Macaca mulatta and Macaca fascicularis, respectively),
were also studied since they are commonly used to model human
diseases and to evaluate efficacy and safety of adenoviral vectors
for gene therapy and genetic vaccines. We reasoned that in these
primates the gut may serve as a site of persistence, and that
evidence of this phenomenon could be obtained from stool
extracts by culture on cells permissive for adenoviral replication or
through a sensitive PCR assay for direct detection of adenoviral
DNA (Table 1).
Non-human primate stool specimens were retrieved from
animals in three distinct living conditions. First, stool from
chimpanzees and gorillas that live in the wild in several locations
in Africa were assayed for the presence of viral genomes by PCR.
Attempts to isolate live, infectious virus from the PCR positive
stool samples were unsuccessful (Table 1) and highlighted the
technical limitations (numbers, quality, condition and preserva-
tion) with specimen from animals in the African wild. In order to
test whether PCR positive stools also harbored live virus, we
obtained more recent stool samples from several primate facilities
in the United States that housed chimpanzees (New Iberia
Research Center of the University of Louisiana at Lafayette, and
the Michale E. Keeling Center for Comparative Medicine and
Research, University of Texas M. D. Anderson Cancer Center)
and macaques (Covance Research Products Inc., Oregon National
Primate Research Center and the Non-human Primate Research
Program at the University of Pennsylvania). Thirdly, we addressed
the question whether the findings from chimpanzees and
macaques extended to other primates by assaying fecal specimens
from several great ape species that lived in captivity in ten different
zoos in the United States.
Table 1. Recovery of adenoviruses from primate stools.
CPE+ PCR+
Chimpanzees
New Iberia 29/82 (35%) 30/30 (100%)
MD Anderson 36/142 (25%) 29/32 (91%)
Zoos 1/11 (9%) 4/11 (36%)
DRC ND 9/24 (42%)
Cameroon ND 18/43 (38%)
Bonobos
Zoos 5/13 (38%) 6/13 (46%)
Gorillas
Zoos 11/45 (24%) 18/45 (40%)
Wild/Africa 0/6 (0%) 3/6 (50%)
Orangutans
Zoos 0/27 (0%) 17/27 (63%)
Humans
USA adults ND 0/18 (0%)
China adults 10/73 (14%) 2/73 (3%)
China children 6/41 (15%) 3/41 (7%)
Macaques
Oregon – rhesus 1/100 (1%) 6/48 (13%)
Covance – rhesus 16/100 (16%) 32/48 (67%)
GTP – rhesus 0/6 (0%) 6/6 (100%)
GTP – cyno 3/42 (7%) 37/42 (88%)
Samples were analyzed by culturing virus on relevant indicator cells or were
subjected to a nested PCR for a highly conserved region of the adenoviral DNA
polymerase gene. All samples that showed cytopathic effect when exposed to
permissive cells were analyzed by a hexon-specific PCR to confirm the presence
of adenovirus. CPE+ indicates the number rescued/total number analyzed
(percentage recovery). PCR+ shows the results of the nested PCR with the
number of PCR positive samples over the total number of samples tested as a
denominator. (ND: not determined).
doi:10.1371/journal.ppat.1000503.t001
Author Summary
Adenoviruses were originally discovered as a causative
agent for upper respiratory infections, especially in
children. They are now recognized as being responsible
for disease in several other settings, e.g., as the cause of
infectious diarrheas or of kerato-conjunctivitis. In the
1960s, chimpanzees were found to shed adenoviruses in
their stools. We now find that normal great apes
(chimpanzees, gorillas, and orangutans) and monkeys
frequently shed adenoviruses in their stools, corroborating
the older finding. In contrast, data from humans have
showed that adenoviral shedding in stools is fairly
uncommon, being restricted to patients recovering from
adenoviral infections, although adenoviruses can frequent-
ly be recovered from lymphoid tissue such as the adenoids
from normal people. In the course of these investigations
we have purified and characterized 30 different adenovi-
ruses from great apes by genomic sequencing. We have
compared the gene sequences of these adenoviruses to 22
human adenoviruses whose complete genome sequences
are available. Even though human adenoviruses are not
found in apes and vice versa, based on these sequence
data we propose that it is possible that cross-species
transmission events may have contributed to the natural
evolution of adenoviruses found to infect humans today.
Non-Human Primate Adenoviruses
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Cameroon and the Democratic Republic of Congo (DRC) were
made available to us for analysis. DNA isolated from these samples
has been used for simian foamy virus studies [20]. These samples
underwent a sensitive nested PCR that was designed to directly
detect adenovirus genomes using oligonucleotides complementary
to a conserved region of the DNA polymerase gene (pol).
Adenovirus DNA could be detected in 40% of the stool samples
from chimpanzees that exist in the wild (Table 1). Cloning and
sequencing of these PCR products identified twenty-four that were
species E and three that were species B (data not shown). In this
conserved region, species E viruses closely clustered with SAdV-
25.1, 26 and 39 whereas species B isolates where mostly similar to
SAdV-35.1 and SAdV-35.2 (Figure 1). We also obtained stool
from mountain gorillas in the Virunga Massif mountain range in
Rwanda and detected adenovirus in 3/6 samples by pol PCR.
Stool extracts were also filtered and evaluated for their ability to
induce cytopathic effects (CPE) on the human epithelial A549 cell
line. Every attempt to grow out live adenovirus on A549 cells was
unsuccessful. We were unable to determine whether this failure
was due to the technical limitations of sample collection or
preservation, the sensitivity of the cellular detection assay or the
absence of functional viral particles. Analysis of samples acquired
under more controlled conditions in the USA permitted us to
address these important questions.
Samples received from USA facilities underwent two parallel
assays. A PCR based assay was designed to detect adenoviral DNA
at high sensitivity and specificity for adenovirus using primers
corresponding to a conserved region of pol as described above. A
second assay aimed to recover replication competent live
adenovirus. The substrates for both assays were the stool
droppings that were re-suspended and filtered. The infectivity of
these adenoviral genomes in great ape fecal specimens was tested
in conditions amenable to replication of human adenoviruses by
inoculating A549 cells and evaluating the cultures for CPE.
Macaque stool was processed identically but cultured on a more
permissive cell line for the growth of macaque adenoviruses than
A549 i.e. an African green monkey epithelial kidney cell line
named BS-C-1. In a subsequent step, CPE positive samples
underwent a PCR assay in which a portion of the hexon gene that
spans hypervariable regions 1 to 6 was amplified [21]. Cloning and
sequencing of these PCR fragments provided confirmation of the
presence of adenovirus and the relatedness of the isolate to other
known adenoviruses. Based on this information, selected samples
were further amplified in culture and complete genomic sequence
was determined.
Of the 568 non-human primate stool samples from zoos and
primate facilities, 18% tested were found to be positive for
adenovirus by the CPE detection assay (Table 1). This assay
provided evidence of shedding of infectious adenovirus for all
species at the time of sampling except for samples from orangutans
which failed to yield infectious virus under the culture condition
employed. Shedding was observed at similar frequencies (22–38%)
among chimpanzees, bonobos and gorillas. The macaque
specimens yielded a substantially lower incidence of CPE (8%).
Of the great ape isolates, all amplified hexon fragments were
sequenced and classified phylogenetically according to adenoviral
species. The 65 PCR positive chimpanzee samples from primate
facilities yielded 15 species B, 28 species C and 23 species E that
clustered in 16 clades based on sequence similarity (.95%
identity). Fifteen representative isolates of the 16 clades were
further amplified and the viral DNA purified and completely
sequenced (Figure 1). Phylogenies of representative open reading
frames (ORFs) of several portions of the genomes largely reflected
the earlier classification based on partial hexon sequence with a
few exceptions (Figure 1 and Figures S1, S2, S3, S4, S5, S6 and
S7). For example, the species E strain SAdV-25.2 encodes a hexon
highly similar to a previous isolate SAdV25.1. Interestingly, the
phylogeny of these two viruses diverges in most other ORFs
studied, suggestive of recombination playing a role in the
evolutionary history of these isolates. Adenoviruses isolated from
zoos belonged mostly to species B (gorilla: 5, bonobo: 2) and
species C (chimpanzee: 2, gorilla: 2, bonobo: 4) with only one
bonobo virus in species E. All zoo isolates were successfully grown
up and fully sequenced. Human species B adenoviruses that have
previously been sub-classified into B:1 (HAdV-3, HAdV-7, and
HAdV-21) and B:2 (HAdV-11, HAdV-34, and HAdV-35) sub-
clades based on restriction enzyme digestions patterns are seen to
cluster separately and are seen to have corresponding counterparts
in the ape adenovirus isolates. SAdV-27, SAdV-28, SAdV-29,
SAdV-32, SAdV-27, SAdV-41, SAdV-46 and SAdV-47 cluster
with the human B:1 isolates whereas SAdV-21, SAdV-33 and
SAdV-35 are more closely related to human B:2 isolates.
A subset of stool samples from each captive population of
non-human primates (experimental facilities and zoos) was
analyzed by direct pol PCR since we hypothesized that the
CPE assay to detect adenovirus in stool likely underestimates the
actual frequency of shedding for two reasons: samples were not
freshly isolated, and the cell line used for recovery was not
necessarily optimal for the respective adenoviruses. Indeed, in
each population studied the detection of adenovirus by PCR was
more sensitive than that based on culture except for humans
where sample collection was carried out under more controlled
conditions followed by culturing on a human cell line (Table 1).
Adenovirus sequence was detected in stools of over 90% of
chimpanzees from the primate facilities, 36% of chimpanzees
from zoos, 46% of bonobos from zoos, and 40% of gorillas from
zoos. Orangutan-derived stool yielded positive PCR signals in
63% of samples despite that fact none of the samples contained
viruses that could be rescued on A549 cells. In macaques, the
increased sensitivity of the PCR diagnostic assay yielded a
higher prevalence in every population studied with overall
evidence of adenoviral shedding in 56% of macaques.
A number of previous studies of adenovirus infections in
humans have attempted to isolate virus from stool samples. Viruses
of the species F group cause infectious diarrhea and are often
isolated from stools of symptomatic individuals [9–14,22]. The
aforementioned natural history studies demonstrated some
examples of prolonged shedding in stool after resolution of
respiratory infections [17,18]. Screening of stool samples from
asymptomatic normal subjects using a variety of techniques has
demonstrated recovery of adenovirus in 2 to 3% of individuals
[23,24]. Our rate of recovery of adenovirus from stools of normal
humans (i.e., no concurrent infectious illness) was similar to those
previously reported, using the same technique used to isolate and
detect adenovirus from great apes (Table 1). Samples were
obtained from several groups who at the time of collection were
not suffering from an infectious illness including adults from USA
(N=18) and adults (N=73) and children (N=41) from China.
Samples from USA were negative by PCR. Samples from China
showed detectable CPE in 14% of adult and children samples,
most of which were confirmed by PCR to be due to adenovirus;
direct analysis of stools by nested primer PCR detected adenovirus
sequence in 3% of adults and 7% of children in China. Most
adenoviruses recovered by CPE and direct PCR analysis were
characterized with respect to sequence across hexon and
polymerase indicating the presence of species B (HAdV-7) and
C (HAdV-2 and 5) viruses as was the case with the great apes;
Non-Human Primate Adenoviruses
PLoS Pathogens | www.plospathogens.org 3 July 2009 | Volume 5 | Issue 7 | e1000503Figure 1. Phylogenetic tree of adenoviruses that infect primates. The tree was reconstructed from an alignment of the polymerase gene,
using maximum likelihood under the HKY85 model of substitutions, as described in Materials and Methods. The names of simian isolates include the
serotype nomenclature, the animal species of isolation (Hu: human, Ch: chimpanzee, Bo: bonobo, Go: gorilla, Cy: cynomolgus macaque, Rh: rhesus
macaque), and the source of adenoviral isolation (ATCC: American Tissue Type Collection, JX: Jacksonville zoo, NI: New Iberia Research Center, MD:
MD Anderson, SD: San Diego zoo, At: Atlanta zoo, LR: Little Rock zoo, BF: Buffalo zoo). Isolates that have a closely related hexon structure are referred
to as variants of the same serotype (‘‘.1’’ or ‘‘.2’’). Names of novel sequences obtained in this study are shown in italics. Colors indicate the six species
of viruses that infect higher primates (A, B, C, D, E, and F); grey is used to indicate viruses isolated from monkeys. The inset (upper left) shows the
same tree with the inclusion of a tree-shrew isolate as an outgroup, after collapsing poorly supported bifurcations. Bootstrap values less than 80% or
close to terminal leaves are suppressed.
doi:10.1371/journal.ppat.1000503.g001
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F (HAdV-41) adenoviruses were also detected.
A total of 30 apparently novel adenoviral genomes (out of 33
that were sequenced) from the great ape samples described above
were sequenced in their entirety and subjected to phylogenetic
analysis, shown in Figure 1 and Figures S1, S2, S3, S4, S5, S6 and
S7. Our analysis also included three viruses we isolated from
cynomolgus macaques (which were completely sequenced), along
with reference sequences from previously published human and
simian isolates as well as a tree shrew-derived isolate [25–27].
Standardized nomenclature is used for the adenoviruses, including
the prefix H or S indicating isolation from a human or simian
source. There was no discernible difference in the genomic
structure of the adenoviruses isolated from great apes and
macaques compared to those isolated from humans, except for
variations in the E3 region [28].
Using maximum likelihood, we constructed phylogenetic trees
based on each of the following gene sequences: DNA polymerase
(Figure 1), E1a (13S mRNA analog encoded, Figure S1), pre-
terminal protein (pTP, Figure S2), hexon (Figure S3), penton base
(Figure S4), protease (Figure S5), ssDNA-binding protein (DBP,
Figure S6), and fiber (Figure S7). Overall, these trees were
concordant with several notable exceptions. For one, species D
branching in E1a and hexon is discordant as compared to the
other proteins studied. Also, the phylogeny of the highly divergent
fiber protein is distinctive and possibly reflective of differences in
receptor usage (CD46 for species B as opposed to Coxsackie
Adenovirus Receptor for the others; species D fibers are known to
additionally bind sialic acid). The phylogeny of species A and F,
and their relationship to the macaque isolates is highly discordant
for the different proteins. The cynomolgus isolates, SAdV-49 and
SAdV-50, for example, are closely associated with species A in E1a
but are either closer to species F or are divergent for the other
proteins. Internally within clades, discordance is also sometimes
noted in species B and E and may be indicative of intra-species
recombination. We used the polymerase tree (Figure 1) as a
reference phylogeny throughout the manuscript. Overall, the
phylogeny of the viral sequences reflects the host species from
which the viruses were isolated. All viruses from great apes and
humans except species A and F viruses form a monophyletic
group, whereas adenoviruses infecting tree shrew, macaques, and
bovines (not shown) fall outside this group [29]. The macaque-
derived viruses SAdV-49 and SAdV-50 were positioned in a
previously uncharacterized clade, yet certain genes have close
resemblance to the same genes in species A and F adenoviruses.
SAdV-48, another macaque-derived virus that we isolated, was
more closely related to SAdV-3 and SAdV-6, both previously
isolated from rhesus macaques (see Figure 1 and Figures S1, S2,
S3, S4, S5, S6 and S7). The viruses isolated from great apes
segregated into distinct clades within the larger groups of species
B, C and E viruses. Human-derived viruses formed separate sub-
clades from ape-derived viruses in each of these viral species.
Reconstructed phylogenies consistently place D viruses in a
monophyletic group with B, C, and E viruses but we did not
identify any simian viruses belonging to species D. The
phylogenies consistently place human A and F viruses in distinct
and somewhat distant clades from all other human viruses. In fact,
the A and F viruses are more closely related to macaque strains
than they are to all other human viruses.
In addition to phylogenetic reconstructions, we also estimated
protein evolutionary rates for the eight genes described above, by
maximum likelihood. In this analysis nucleotide substitutions that
change the amino acid sequence (dN) are compared to nucleotide
substitutions that are silent (dS). All genes showed a predominance
of selection against protein-coding substitutions (dN/dS,1 in all
cases, mean dN/dS=0.134) which is consistent with the
corresponding proteins having structural constraints and playing
an important role in the fitness of the virus. We also computed
branch-specific dN/dS values for viruses that infect human versus
non-human hosts. We found a significant elevation of dN/dS
(p,0.0001) for the fiber gene along human-host lineages (dN/
dS=0.270) as compared non-human-host lineages (dN/
dS=0.208). This result is consistent with increased pressure on
the evolution of the fiber proteins in humans relative to primates
(or relaxed negative selection), which may be mediated by
humoral immunity since the fiber is exposed on the surface of
the virus.
The analyses described above highlighted discordant phyloge-
nies suggestive of recombination. To address this question more
specifically, we subjected sequence datasets from every indepen-
dent source of isolation to a computational analysis designed to
detect recombination events. We performed a sliding window
analysis of identity and bootstrap values of separate isolates in
relation to the query sequence across the genome. Figure 2
illustrates a sliding window analysis of identity on SAdV-27.1, the
most obvious example of recombination among viruses from the
same location. SAdV-27.1, which is an isolate from the New Iberia
chimpanzee facility, was queried against a number of related
genomes including 3 other chimpanzee clade B isolates from the
same combine (SAdV-32, SAdV-33, SAdV-35.1), a gorilla isolate
with a highly identical hexon sequence (SAdV-27.2), and several
reference isolates that served as outgroups (SAdV-31 and SAdV-
38). This analysis revealed close identity at the left and extreme
right ends between two species B.1 viruses of the same chimpanzee
facility (SAdV-32 and SAdV-33) and the gorilla-derived
SAdV27.2. Remarkably, the region starting on the left within
the DBP open reading frame and extending to the end of the E3
locus was almost identical to the species B.2 isolate, SAdV-35.1,
from the same facility. These findings identify SAdV-27.1 as a
hybrid B.1-B.2 virus that was generated following a recombination
event that occurred in the New Iberia compound between SAdV-
35.1 or a very similar virus and a B.1 strain more distantly related
to SAdV-32 and SAdV-33. Given that SAdV-35.1 and SAdV27.1
were received over 1 month apart, isolated from distinct combines
at different dates and in distinct experiments, we excluded this
recombination event as an in vitro culture artifact. These data
illustrate the potential for intra-species recombination of adeno-
viruses and identify the first hybrid B.1–B.2 adenovirus.
Discussion
We have detected a high prevalence of adenoviruses in the
stools of apparently healthy animals of several great ape and
macaque species. The high rate of shedding was surprising and
suggests that adenoviruses are capable of establishing chronic
infections following an initial exposure that may or may not be
clinically relevant. The presence of adenovirus in stools from wild
chimpanzees and gorillas across several countries in central Africa
confirmed that this was not an artifact of animals being
maintained in captivity. Our studies cannot rule out an alternative
explanation in which animals are repeatedly infected although
these infections would have to be prolonged and frequent to
explain the high prevalence. There is substantially less shedding of
virus in human stool although adenovirus genomes are highly
prevalent and abundant in gut associated lymphoid tissue (data not
shown). Analyses of host responses to these persistent/latent
infections suggests that better control of the chronic infection in
humans may be due to a more effective T cell response to the virus
Non-Human Primate Adenoviruses
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the disseminated and often lethal adenovirus infections observed in
human patients who are immune suppressed [30,31].
Sequencing the complete genomes of the 33 novel adenoviruses
(30 different sequences were found) that we have isolated from
chimpanzees and gorillas has allowed us to examine the
phylogenetic relationships among hominid adenoviruses. Overall,
we found that the viruses isolated from great apes fall into the
three species groups (B, C, and E) previously believed to be
primarily of human origin. Generally, most DNA viruses are
thought to have evolved with their host in a mechanism referred to
as co-evolution [32] in which the virus was a pathogen of a
common ancestor. Subsequent viral speciation is then expected to
mirror primate speciation. In fact, the primate species C
adenovirus phylogeny in this study is largely consistent with this
hypothesis. However, several elements of the data, particularly in
adenoviral species B and E, suggest that co-evolution alone may
not fully explain the observed diversity and indicate a contribution
of cross-species transmission to the primate adenoviral evolution-
ary history. Indeed, within species B and species D, the distances
between certain human and ape adenovirus proteins are smaller
than predicted by co-evolution, which is supported by high
bootstrap values. In addition, partial hexon sequence of chimpan-
zee species C isolates that we were unable to grow out to obtain a
full length sequence were found to cluster tightly with gorilla
isolates indicating a possible cross-species transmission event in this
Figure 2. Evidence for intra-species B recombination within the New Iberia chimpanzee colony. A Simplot analysis of New Iberia species
B adenoviral isolates aligned with a schematic annotated genomic structure of the SAdV-27.1 showing evidence of an incidence of recombination
between viral isolates from the same compound. The analysis demonstrates homology on the left genomic end extending up to the DNA Binding
Protein (DBP) open reading frame with various species B isolates from within one subspecies (represented by SAdV-32) from the New Iberia
chimpanzee colony, followed by an 100K, 22K, 33K and partial E3 gene region of near complete identity to the structurally distinct New Iberia isolate
SAdV-35.1 of a distinct subspecies within species B. To the right of this region of identity the homology transitions to the fiber region first to B isolate
SAdV-33 and subsequently to SAdV-32 again. Further evidence is provided by SAdV-27.2, isolated from a gorilla in a different geographical location
(Atlanta zoo). This genome is closely related to SAdV-27.1 and is almost identical in hexon but did not undergo the presumed recombination event
between DBP and E3. The left and extreme right ends of the SADV-27.1 genome demonstrate close but not complete identity to SAdV-32 indicating a
close relationship to the putative parental adenovirus of this event of homoplasy. The left junction of the recombination event is a clearly defined
junction centrally in the DNA binding protein as indicated by the dotted blue line. The right end junction was less well-defined due to a region of lack
of complete identity in the fiber-proximal part of the coding region of the E3 gene family. This region is indicated by the dotted blue lines in the
sequence. The more distantly related species B isolate SAdV-35, species C isolate SAdV-31 and species E isolate SAdV-38 (all isolated from the New
Iberia chimpanzee colony) are provided in the analysis as reference.
doi:10.1371/journal.ppat.1000503.g002
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evolution hypothesis, one would expect the evolutionary distances
between adenovirus species from humans to be similar to those
from apes, assuming similar selective pressures. On the contrary,
we observe that these distances are indeed very variable. For
example, in clade B, SAdV-33 is only 0.018 substitutions/site
removed from the human clade B.1 whereas the SAdV-35 viruses
are almost 10 times more removed from the human clade B.2
viruses (0.170 substitutions/site). We may interpret these data as
either evidence for dramatic differences in selective pressures or an
indication of at least one, possibly two, independent cross-species
transmission events at distinct points in time. When one applies
conservative molecular clock estimates for DNA viruses [33], the
time estimates of the divergence between close human and ape
viruses in species B and E are also inconsistent with the date of the
human-chimpanzee divergence.
Thus, we have demonstrated that cross-species transmission can
be invoked to explain some of the phylogenetic relationships
among human- and ape-infecting adenovirus isolates within the B
and E species. We speculate that this transmission occurred from
great apes to humans. The opposite direction of transmission
cannot be ruled out, but is unlikely given the epidemiological
evidence in favor of great apes as the natural host species.
Several limitations to the data prevent us from delineating a
definitive model of evolutionary history of primate adenoviruses.
First, the inability to isolate adenoviruses from certain clades or
host species of non-human hosts may indicate either their
extinction in that particular host or a failure to detect the virus
to date due to limitations in sampling or assaying. These
limitations make it extremely difficult to perform an exhaustive
study and nor can the data be interpreted as such. This study does,
however, provide the most extensive survey of non-human primate
adenoviruses to date. It is clear that more extensive studies in
primates, particularly those in great apes in the wild are
warranted. All full-length adenoviral genomes presented here
were isolated from animals in captivity yet limited pol sequence
data from gorillas and chimpanzees in the wild provide
preliminary evidence to confirm the fecal shedding of species B
and E viruses. As stated in Results, the samples from the wild
harbored predominantly species E sequences as determined by
PCR amplification of the polymerase gene (24 belonging to species
E and 3 to species B) whereas we were able to detect considerable
numbers of species C adenoviruses (in addition to species E and B)
in captivity. It can be speculated that the prevalence of the
different adenovirus species in the gut of captive apes may be
skewed as a result of captivity, but clearly more data including
virus isolation in the wild is necessary in order to definitively
confirm this observation.
The high prevalence of adenovirus shedding in great apes and
their close relation to existing human adenoviruses suggest a
potential risk of ape-to-human transmission. This risk will likely be
higher where contacts are more prevalent, such as with captive
and habituated animals. The limited available sero-epidemiolog-
ical data for chimpanzee species B and E adenoviruses suggests
this may be the case in areas home to common chimpanzee species
[34]. In addition, the possibility that the adenoviruses that were
isolated from animals in combines and zoos were an artifact of
their captivity needs to be addressed. In fact these concerns were
aired following the isolation of SAdV-22, SAdV-23, SAdV-24,
SAdV-25 [27]. In that study, none of the animal handlers who
were exposed to the chimpanzees were found to harbor antibodies
to the chimpanzee adenoviruses. More recently, serum samples
from 50 zoo workers were tested for the presence of neutralizing
antibodies to SAdV-E (SAdV-23 and SAdV-25) and SAdV-B
(SAdV-21), and none was found [35]. Although macaques shed
adenovirus at high levels, transmission to humans seems unlikely
since the macaque viruses are quite distinct from most known
human adenoviruses. It is interesting however that an adenovirus
similar to the macaque viruses was isolated from a patient with
gastroenteritis [36].
These studies should also be considered in the context of
applications of recombinant adenoviruses as vectors for human
gene therapy and genetic vaccines. Chronic infections and latency
of viruses and the associated host immune responses may
confound the application of vectors that are related to these
endogenous viruses.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the University of Pennsylvania Institutional
Animal Care and Use Committee, and all animal work was
approved by this committee.
Isolation of novel adenoviruses from stool
Stool samples were collected at the facilities that house the
animals and were suspended in Hanks’ Balanced Salt Solution
(HBSS), and sent to University of Pennsylvania on ice. The
particulates were removed by centrifugation, and the supernatant
was sterile filtered through 0.2 mm syringe filters. 100 ml of each
filtered sample was inoculated into A549 cells grown in Ham’s F12
medium with 10% fetal bovine serum (FBS), 1% Penn-Strep and
50 mg/ml gentamicin. After about 1 to 2 weeks in culture, visual
CPE was obvious in cell cultures with several of the inoculates.
The presence of adenoviruses in the cultures was confirmed by
PCR amplification of an internal 1.9 kb of the hexon – the region
encompassing the hypervariable regions and that is predominantly
responsible for conferring serotype specificity. The primer pair
that was utilized for PCR was CAGGATGCTTCGGAG-
TACCTGAG and TTGGCNGGDATDGGGTAVAG-
CATGTT. The sequence obtained from this region was used to
make an initial determination of adenoviral species and novelty of
the serotype. Adenoviral isolates were plaque purified on A549
cells, propagated to high titer and purified on cesium chloride
gradients using standard procedures. Viral DNAs obtained from
purified virus preparations were completely sequenced (Qiagen
Genomics Services, Hilden, Germany). In addition, a sensitive
nested PCR specific for the DNA polymerase gene with outer
primers, TGATGCGYTTCTTACCTYTGGTYTCCATGAG
and AGTTYTACATGCTGGGCTCTTACCG, and inner prim-
ers, GTGACAAAGAGGCTGTCCGTGTCCCCGTA and
TCACGTGGCCTACACTTACAAGCCAATCAC, was used as
a specific diagnostic for adenoviral shedding.
Gene finding
We selected 8 genes to use for the subsequent phylogenetic
analysis: fiber, hexon, penton base, protease, E1A, DNA-binding
protein (DBP), polymerase, terminal protein precursor (pTP). We
used the annotated simian adenovirus genome SAdV-25.2 as a
reference to find the coding sequences of these genes in the un-
annotated (target) genomes. To detect a gene in a target genome,
we performed the following procedure: 1) we extracted the focal
gene from the reference genome and aligned it to the target
genome. This gave us a rough location of the focal gene in the
target genome; 2) we detected all ORFs in the target genome that
overlapped with the aligned region; 3) if the gene was known to
have an intron (E1A, polymerase and pTP and DNA polymerase
Non-Human Primate Adenoviruses
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preserved the length of the first exon up to 30% and the length of
the intron up to 60% with respect to the reference gene; all such
potential introns were spliced out, generating a pool of potential
coding sequences; 4) for each coding sequence from this pool, we
aligned the corresponding amino acid sequence to the reference
amino acid sequence; 5) we sorted the coding sequences according
the their alignment score. The coding sequence with the highest
score was considered to be the coding sequence for the focal gene
in the target genome. All alignments were performed with the
ClustalW v. 2.0.9 software [37].
Phylogenetic analysis
From the resulting nucleotide sequence alignments for each
gene, we reconstructed the phylogenetic trees using the PhyML
software [38] under the HKY85 model [39] with a transition/
transversion ratio, fraction of invariable sites and the discretized
gamma distribution of rates across sites [40]. To assess the
reliability of the reconstructed phylogenies, we performed 100
bootstrap reconstructions for each gene.
In order to accurately estimate the evolutionary rates within the
B, C, E and D species, we removed all adenoviruses isolated from
Old World monkeys as well as HAdV-40 and HAdV-12 isolates.
We then aligned the remaining protein sequences and back-
translated them to DNA using the PAL2NAL software [41]. We
then reconstructed the phylogenies for this subset of data under
the same model as before. Finally, we applied the PAML software
[42] under the branch-specific model to estimate the dN/dS ratios
on different branches keeping the branch lengths fixed. Internal
analysis of identity was done by SIMPLOT sliding window
analysis (window: 1000 bp, step: 20 bp) [43]. Bootscanning
analysis was performed in order to confirm the apparent mosaic
pattern of recombination [44].
Sequence data
In addition to isolates sequenced in this study, the following
complete annotated human and simian adenovirus genomes from
GenBank were used: NC_010956 (HAdV-9), NC_003266
(HAdV-4), NC_004001 (HAdV-11), NC_001460 (HAdV-12),
NC_001405 (HAdV-2), DQ900900 (HAdV-37), AC_000019
(HAdV-35), AC_000017 (HAdV-1), AC_000008 (HAdV-5),
NC_001454 (HAdV-40), DQ923122 (HAdV-52), EF153474
(HAdV-26), EF153473 (HAdV-48), DQ393829 (HAdV-49),
AY601633 (HAdV-21), AY599836 (HAdV-3), AY594256
(HAdV-7), AY601636 (HAdV-16), AY875648 (HAdV-46),
AY737797 (HAdV-34), AY803294 (HAdV-14), AY737798
(HAdV-50), AY771780 (SAdV-1), AY598782 (SAdV-3),
CQ982401 (SAdV-6), DQ792570 (SAdV-7), AC000010 (SAdV-
21), AY530876 (SAdV-22), AY530877 (SAdV-23), AY530878
(SAdV-24), AC000011 (SAdV-25). All novel adenoviral sequences
(SAdV20, SAdV25.2 to SAdV-48) are available in GenBank
(FJ025899-FJ025931).
Supporting Information
Figure S1 Phylogeny of the adenoviral E1a gene. Maximum
likelihood analysis under the HKY85 model of substitutions, as
described in Materials and Methods and in the legend to Figure 1.
Found at: doi:10.1371/journal.ppat.1000503.s001 (2.44 MB TIF)
Figure S2 Phylogeny of the adenoviral pre-terminal protein
(pTP) gene. Maximum likelihood analysis under the HKY85
model of substitutions, as described in Materials and Methods and
in the legend to Figure 1.
Found at: doi:10.1371/journal.ppat.1000503.s002 (2.46 MB TIF)
Figure S3 Phylogeny of the adenoviral hexon gene. Maximum
likelihood analysis under the HKY85 model of substitutions, as
described in Materials and Methods and in the legend to Figure 1.
Found at: doi:10.1371/journal.ppat.1000503.s003 (2.59 MB TIF)
Figure S4 Phylogeny of the adenoviral penton base gene.
Maximum likelihood analysis under the HKY85 model of
substitutions, as described in Materials and Methods and in the
legend to Figure 1.
Found at: doi:10.1371/journal.ppat.1000503.s004 (2.54 MB TIF)
Figure S5 Phylogeny of the adenoviral protease gene. Maxi-
mum likelihood analysis under the HKY85 model of substitutions,
as described in Materials and Methods and in the legend to
Figure 1.
Found at: doi:10.1371/journal.ppat.1000503.s005 (2.52 MB TIF)
Figure S6 Phylogeny of the adenoviral DNA-binding protein
(DBP) gene. Maximum likelihood analysis under the HKY85
model of substitutions, as described in Materials and Methods and
in the legend to Figure 1.
Found at: doi:10.1371/journal.ppat.1000503.s006 (2.50 MB TIF)
Figure S7 Phylogeny of the adenoviral fiber gene. Maximum
likelihood analysis under the HKY85 model of substitutions, as
described in Materials and Methods and in the legend to Figure 1.
Found at: doi:10.1371/journal.ppat.1000503.s007 (2.55 MB TIF)
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